Forecasting annual incidence and mortality rate for prostate cancer in Australia until 2022 using autoregressive integrated moving average (ARIMA) models by Sue M Evans, Arul Earnest, Fanny Sampurno, Jeremy Millar

Get full text

Toward value-based care using cost mining: cost aggregation and visualization across the entire colorectal cancer patient pathway by Maura Leusder, Sven Relijveld, Derya Demirtas, Jon Emery, Michelle Tew, Peter Gibbs, Jeremy Millar, Victoria White, Michael Jefford, Fanny Franchini, Maarten IJzerman

Get full text

A population‐based analyses of the evolving management of cN1M0 prostate cancer in the PSMA‐PET era by Jennifer Ward, Kevin Armstrong, Therese Min‐Jung Kang, Jodie Tham, Yuan‐Hong Lin, Marcus Cheng, Jeremy Grummet, Nathan Lawrentschuk, Marlon Perera, Shomik Sengupta, David Chang, Michael Ng, Jonathan Bensley, Michelle Steeper, Krupa Krishnaprasad, Maggie Johnson, Nikolajs Zeps, Jeremy Millar, Wee Loon Ong

Get full text

TROG 18.01 phase III randomised clinical trial of the Novel Integration of New prostate radiation schedules with adJuvant Androgen deprivation: NINJA study protocol by Colin I Tang, Christopher Oldmeadow, Jeremy Millar, Jarad Martin, Paul Keall, Shankar Siva, Peter Greer, David Christie, Kevin Moore, Jason Dowling, David Pryor, Peter Chong, Nicholas McLeod, Avi Raman, James Lynam, Joanne Smart, Declan G Murphy, Keen Hun Tai, Lois Holloway, Penny Reeves, Amy Hayden, Tee Lim, Tanya Holt, Mark Sidhom

Get full text